PDB0306 Incidence of HCV reinfection among HIV-positive MSM and its association with sexual risk behavior: A longitudinal analysisPoster exhibitionB12
PDB0402 HIV-1 DNA testing in viremic patients demonstrates a greater ability to detect drug resistance compared to plasma virus testingPoster exhibitionB7
PDB0403 HIV-infected treatment-experienced children and adolescents from Sub-Saharan Africa: Clinical outcomes on third-line antiretroviral treatment in the New Horizons drug donation programPoster exhibitionB51
PDB0404 Deep sequencing with unique molecular identifiers for evaluation of HIV-1 drug resistance in the DISCOVER pre-exposure prophylaxis trialPoster exhibitionB7
PDB0405 Pretreatment low-frequency HIV drug resistance mutations in antiretroviral naive individuals in BotswanaPoster exhibitionB7
PDB0406 Doravirine resistance profile in clinical isolates and impact of baseline NNRTI resistance-associated mutations observed in treatment-naïve participants from phase 3 clinical trialsPoster exhibitionB35
PDB0407 Surveillance of transmitted HIV drug resistance among treatment-naïve children under 18 months in Brazil (2009-2018)Poster exhibitionB7
PDC0102 High PrEP adherence in men who have sex with men and transgender women cohort in Manila, Philippines: Evidence of HIV protective levels from tenofovir blood concentrations in project PrEPPYPoster exhibitionC47
PDC0103 Adherence to daily and event-driven pre-exposure prophylaxis among men who have sex with men in TaiwanPoster exhibitionC47
PDC0104 Project My PrEP: Results from a PrEP demonstration project among high risk men who have sex with men (MSM) in Kuala Lumpur, MalaysiaPoster exhibitionC35
seek-warrow-warrow-eseek-e31 - 40 of 2297 items